Brian is a patent attorney with a practice that focuses primarily on patent prosecution, due diligence, and portfolio management in the areas of biotechnology, pharmaceuticals and medical devices. He has spent the last decade working with dozens of universities, and numerous early and growth stage biotechnology and medical device companies, to develop patent portfolios individualized for his client's unique needs and intended markets. Prior to this, Brian spent another decade conducting research in the areas of immunogenetics, endocrinology, infectious disease, cardiology, developmental biology, cell biology, and molecular biology.
Brian has used his extensive technical and legal experience to protect a wide variety of technologies, including stem cells, recombinant proteins, synthetic peptides, oligonucleotides, viral vectors, antibodies, biomarkers, biomaterials, nanoparticles and microparticles, tissue engineering techniques and reagents, diagnostics, medical devices, and therapeutic methods. Brian's experience includes drafting patent applications; preparing invalidity, freedom to operate, and non-infringement opinions; prosecuting U.S. and foreign patent applications; and advising companies and investors durip I.P. due diligence.